The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm.

Zhu, Sipin; Sun, Ping; Bennett, Samuel; Charlesworth, Oscar; Tan, Renxiang; Peng, Xing; Gu, Qiang; Kujan, Omar; Xu, Jiake

Zhu, Sipin; Sun, Ping; Bennett, Samuel; Charlesworth, Oscar; Tan, Renxiang; Peng, Xing; Gu, Qiang; Kujan, Omar; Xu, Jiake.

Afiliación

Zhu S; Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Sun P; School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
Bennett S; School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
Charlesworth O; Department of Endocrinology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Tan R; School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
Peng X; School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
Gu Q; The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Functional Biomolecules, Nanjing University, Nanjing, China.
Kujan O; Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Xu J; Research Center for Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.

Front Pharmacol ; 14: 1111218, 2023.

Article en En | MEDLINE | ID: mdl-37033622

Palabras clave

cancers; inflammation; osteolysis; parthenolide; skeletal diseases

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google